Country: Kanada
Bahasa: Inggeris
Sumber: Health Canada
FOLLITROPIN ALFA
EMD SERONO, A DIVISION OF EMD INC., CANADA
G03GA05
FOLLITROPIN ALFA
77MCG
POWDER FOR SOLUTION
FOLLITROPIN ALFA 77MCG
INTRAMUSCULAR
2ML
Prescription
GONADOTROPINS AND ANTIGONADOTROPINS
Active ingredient group (AIG) number: 0145621006; AHFS:
CANCELLED POST MARKET
2019-04-30
_ _ Gonal-f Product Monograph Page 1 of 43 PRODUCT MONOGRAPH Pr GONAL-F ® Follitropin alfa for Injection 75 IU (5.5 µg), 450 IU (33 µg) and 1050 IU (77 µg) Lyophilized powder for reconstitution Pharmaceutical Standard: Professed Therapeutic Classification: Gonadotropin EMD Serono, A Division of EMD Inc., Canada 2695 North Sheridan Way, Suite 200 Mississauga ON L5K 2N6 Date of Initial Approval: September 19, 2003 Date of Revision: May 3, 2019 Submission Control No: 224799 ® Registered trademark of Merck KGaA, Darmstadt, Germany _ _ Gonal-f Product Monograph Page 2 of 43 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ........................................................ 4 SUMMARY PRODUCT INFORMATION ....................................................................... 4 DESCRIPTION................................................................................................................... 4 INDICATIONS AND CLINICAL USE ............................................................................. 4 CONTRAINDICATIONS .................................................................................................. 5 WARNINGS AND PRECAUTIONS ................................................................................. 5 General .................................................................................................................... 5 Overstimulation of the Ovary During FSH Therapy .............................................. 6 Carcinogenesis and Mutagenesis ............................................................................ 7 Respiratory and Cardiovascular .............................................................................. 8 Dependence/Tolerance ............................................................................................ 8 Sexual Function/Reproduction................................................................................ 8 Special Populations ......................................................................................... Baca dokumen lengkap